JP2004536558A - Src−2発現のアンチセンスモジュレーション - Google Patents
Src−2発現のアンチセンスモジュレーション Download PDFInfo
- Publication number
- JP2004536558A JP2004536558A JP2002545129A JP2002545129A JP2004536558A JP 2004536558 A JP2004536558 A JP 2004536558A JP 2002545129 A JP2002545129 A JP 2002545129A JP 2002545129 A JP2002545129 A JP 2002545129A JP 2004536558 A JP2004536558 A JP 2004536558A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- src
- oligonucleotide
- oligonucleotides
- antisense
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/334—Modified C
- C12N2310/3341—5-Methylcytosine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/341—Gapmers, i.e. of the type ===---===
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/346—Spatial arrangement of the modifications having a combination of backbone and sugar modifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72353000A | 2000-11-27 | 2000-11-27 | |
| PCT/US2001/044220 WO2002042423A2 (en) | 2000-11-27 | 2001-11-26 | Antisense modulation of src-2 expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004536558A true JP2004536558A (ja) | 2004-12-09 |
| JP2004536558A5 JP2004536558A5 (enExample) | 2005-05-19 |
Family
ID=24906651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002545129A Withdrawn JP2004536558A (ja) | 2000-11-27 | 2001-11-26 | Src−2発現のアンチセンスモジュレーション |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1343913A2 (enExample) |
| JP (1) | JP2004536558A (enExample) |
| AU (1) | AU2002237678A1 (enExample) |
| WO (1) | WO2002042423A2 (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8142198A (en) * | 1997-06-12 | 1998-12-30 | Regents Of The University Of California, The | A transcription factor coactivator protein, p/cip |
-
2001
- 2001-11-26 JP JP2002545129A patent/JP2004536558A/ja not_active Withdrawn
- 2001-11-26 AU AU2002237678A patent/AU2002237678A1/en not_active Abandoned
- 2001-11-26 EP EP01986485A patent/EP1343913A2/en not_active Withdrawn
- 2001-11-26 WO PCT/US2001/044220 patent/WO2002042423A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002042423A2 (en) | 2002-05-30 |
| EP1343913A2 (en) | 2003-09-17 |
| WO2002042423A3 (en) | 2003-01-30 |
| AU2002237678A1 (en) | 2002-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4054192B2 (ja) | Ptp1b発現のアンチセンス阻害 | |
| JP4397585B2 (ja) | クラスタリン発現のアンチセンスモジュレーション | |
| JP2003505351A (ja) | Mapキナーゼキナーゼ6発現のアンチセンスモジュレーション | |
| JP2004509619A (ja) | Flip−c発現のアンチセンスモジュレーション | |
| JP2003520241A (ja) | Mekk2発現のアンチセンスモジュレーション | |
| JP2003520584A (ja) | カスパーゼ3発現のアンチセンスモジュレーション | |
| JP2003503048A (ja) | Ship−2発現のアンチセンスモジュレーション | |
| JP2003520586A (ja) | Smad7発現のアンチセンスモジュレーション | |
| JP2003505027A (ja) | Pi3キナーゼp110デルタ発現のアンチセンスモジュレーション | |
| JP2003520042A (ja) | 誘導性一酸化窒素シンターゼ発現のアンチセンスモジュレーション | |
| JP2003505062A (ja) | Pten発現のアンチセンスモジュレーション | |
| AU768799B2 (en) | Antisense modulation of integrin-linked kinase expression | |
| JP2003505063A (ja) | Mekk5発現のアンチセンスモジュレーション | |
| JP2003508089A (ja) | PI3キナーゼp110ベータ発現のアンチセンスモジュレーション | |
| JP2003520585A (ja) | ペルオキシソーム増殖因子−活性化受容体ガンマ発現のアンチセンスモジュレーション発現のアンチセンスモジュレーション | |
| JP2003505092A (ja) | Shp−2発現のアンチセンスモジュレーション | |
| JP2003520051A (ja) | Pepck−サイトゾル発現のアンチセンスモジュレーション | |
| JP2003505026A (ja) | 肝臓グリコーゲンホスホリラーゼ発現のアンチセンスモジュレーション | |
| JP2003525058A (ja) | E2f転写因子1発現のアンチセンスモジュレーション | |
| JP2003531630A (ja) | Dna結合阻害剤−1発現のアンチセンスモジュレーション | |
| JP2004503232A (ja) | C/EBPβ発現のアンチセンスモジュレーション | |
| JP2003518928A (ja) | Akt−3発現のアンチセンスモジュレーション | |
| JP2003527085A (ja) | Pepck−ミトコンドリア発現のアンチセンスモジュレーション | |
| JP2003512079A (ja) | タンパク質キナーゼc−シータ発現のアンチセンスモジュレーション | |
| JP2005525829A (ja) | 糖質コルチコイド受容体発現のアンチセンス調節 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20050204 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050328 |